SREBF1 and breast cancer: Reports suggest that this substance may inducing apoptosis in BC cells by reprogramming fatty acid metabolism, predominantly through the suppression of lipogenesis by inhibiting the expression of sterol regulatory element-binding protein 1 (SREBP-1) and its target genes in the de novo FAS pathway.